Van der Schyf, Cornelis J <br/><br/>
Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases.  [electronic resource] 

 -  Expert opinion on investigational drugs  Aug 2006 
 - 873-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.15.8.873  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--metabolism<br/>Adenosine A2 Receptor Antagonists<br/>Animals<br/>Apoptosis--drug effects<br/>Calcium--metabolism<br/>Calcium Channel Blockers--pharmacology<br/>Carbamates--pharmacology<br/>Cholinesterase Inhibitors--pharmacology<br/>Drug Design<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Free Radical Scavengers--pharmacology<br/>Humans<br/>Hydroxyquinolines--pharmacology<br/>Iron Chelating Agents--pharmacology<br/>Monoamine Oxidase Inhibitors--pharmacology<br/>Neurodegenerative Diseases--drug therapy<br/>Neuroprotective Agents--pharmacology<br/>Piperazines--pharmacology<br/>Purines--pharmacology<br/>Receptor, Adenosine A2A--metabolism<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Serotonin Plasma Membrane Transport Proteins--metabolism<br/>Selective Serotonin Reuptake Inhibitors--pharmacology